Yeasen Biotechnology (Shanghai) Co., Ltd.
PrivateLast Round
Series B
Extension
Aug 26, 2021
Total Funding Raised
$93.15M
Company Overview
Yeasen Biotechnology (Shanghai) Co., Ltd. operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series B Extension round in August 2021.
Yeasen Biotechnology (Shanghai) Co., Ltd. is a biotechnology company that researches, develops, manufactures, and sells biological reagents including molecules, proteins, and cells for life science research, diagnostics, and biopharmaceuticals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Yeasen Biotechnology (Shanghai) Co., Ltd. Comparables
Compare Yeasen Biotechnology (Shanghai) Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nanjing Vazyme Biotech Co Ltd | 85% | |
| TransGen Biotech Co., Ltd. | 82% | |
| Hzymes Biotechnology Co., Ltd. | 81% |
For institutional investors. Book with your work email.
Yeasen Biotechnology (Shanghai) Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Aug 26, 2021 | ||||
| Series B | Jul 16, 2021 | ||||
| Series A | Jul 1, 2020 |
For institutional investors. Book with your work email.
Yeasen Biotechnology (Shanghai) Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Huimei Capital | Series B Extension |
| Legend Capital | Series B Extension, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 16, 2021
$39M round led by Legend Capital.
- Jul 1, 2020
Raised $9M in Series A funding.
For institutional investors. Book with your work email.
Yeasen Biotechnology (Shanghai) Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Yeasen Biotechnology (Shanghai) Co., Ltd.'s valuation, stock price, and market status.
Is Yeasen Biotechnology (Shanghai) Co., Ltd. a public or private company?
Yeasen Biotechnology (Shanghai) Co., Ltd. is a private company.
What is the current stock price of Yeasen Biotechnology (Shanghai) Co., Ltd.?
Yeasen Biotechnology (Shanghai) Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Yeasen Biotechnology (Shanghai) Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Yeasen Biotechnology (Shanghai) Co., Ltd. worth (valuation)?
Valuation information for Yeasen Biotechnology (Shanghai) Co., Ltd. is not publicly available.
Can I buy Yeasen Biotechnology (Shanghai) Co., Ltd. stock?
Yeasen Biotechnology (Shanghai) Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Yeasen Biotechnology (Shanghai) Co., Ltd.'s last funding round?
Yeasen Biotechnology (Shanghai) Co., Ltd.'s most recent funding round was Series B Extension on August 26, 2021.
Who are the main investors in Yeasen Biotechnology (Shanghai) Co., Ltd.?
Key investors in Yeasen Biotechnology (Shanghai) Co., Ltd. include Legend Capital.
Will Yeasen Biotechnology (Shanghai) Co., Ltd. IPO soon?
No public IPO plans have been announced for Yeasen Biotechnology (Shanghai) Co., Ltd..
How can I track Yeasen Biotechnology (Shanghai) Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Yeasen Biotechnology (Shanghai) Co., Ltd.'s shares on secondary markets.